Literature DB >> 17511598

Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.

Kevin Dysart1, Hui-Chen Hsieh, Karol Kaltenbach, Jay S Greenspan.   

Abstract

OBJECTIVE: We determined the effect of preterm delivery on the course of neonatal abstinence syndrome (NAS) in infants born to mothers participating in a methadone maintenance program. STUDY
DESIGN: A retrospective cohort study was conducted in which infant and maternal data were collected from the medical records of 53 preterm and 66 term infants. Infants were selected from all infants admitted to Thomas Jefferson University hospital born between 1998 and 2002 whose mothers were enrolled in the methadone maintenance program. All infants were managed by a standard protocol utilizing the Neonatal Abstinence Scoring System (NASS) and neonatal opiate solution (NOS). Preterm and term infants were compared.
RESULTS: Preterm infants had shorter lengths of stay, treatment courses and required less medication than did term infants during the same time period.
CONCLUSION: These data indicate that following exposure to maternal methadone, preterm infants have a different neonatal course than do infants born at term.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511598     DOI: 10.1515/JPM.2007.063

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  15 in total

1.  Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.

Authors:  Walter K Kraft; Kevin Dysart; Jay S Greenspan; Eric Gibson; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Addiction       Date:  2010-10-06       Impact factor: 6.526

2.  Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.

Authors:  Walter K Kraft; Susan C Adeniyi-Jones; Inna Chervoneva; Jay S Greenspan; Diane Abatemarco; Karol Kaltenbach; Michelle E Ehrlich
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

3.  Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Authors:  Teresa R Gray; Robin E Choo; Marta Concheiro; Erica Williams; Andrea Elko; Lauren M Jansson; Hendreé E Jones; Marilyn A Huestis
Journal:  Addiction       Date:  2010-09-20       Impact factor: 6.526

Review 4.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

5.  Neonatal abstinence syndrome--postnatal ward versus neonatal unit management.

Authors:  Tolulope Saiki; Silke Lee; Simon Hannam; Anne Greenough
Journal:  Eur J Pediatr       Date:  2009-05-14       Impact factor: 3.183

6.  The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.

Authors:  Lara S Lemon; Ashley Naimi; Steve N Caritis; Robert W Platt; Raman Venkataramanan; Lisa M Bodnar
Journal:  Paediatr Perinat Epidemiol       Date:  2018-01-26       Impact factor: 3.980

7.  Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants.

Authors:  Elizabeth Allocco; Marjorie Melker; Florencia Rojas-Miguez; Caitlin Bradley; Kristen A Hahn; Elisha M Wachman
Journal:  Adv Neonatal Care       Date:  2016-10       Impact factor: 1.968

8.  Confounding of the Comparative Safety of Prenatal Opioid Agonist Therapy.

Authors:  Susan B Brogly; Kristen A Hahn; Sonia Hernandez Diaz; Martha Werler
Journal:  J Addict Res Ther       Date:  2015-12-31

9.  Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Authors:  Karol Kaltenbach; Amber M Holbrook; Mara G Coyle; Sarah H Heil; Amy L Salisbury; Susan M Stine; Peter R Martin; Hendrée E Jones
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

10.  Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol.

Authors:  Melissa R Johnson; David R Nash; Mary R Laird; Robert C Kiley; Michael A Martinez
Journal:  J Pediatr Pharmacol Ther       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.